Much as I love the market (I'm a Hayek groupie), I think there's a free rider problem here. Why would Bayer invest in improving the market for aspirin (paying f

Much as I love the market (I'm a Hayek groupie), I think there's a free rider problem here. Why would Bayer invest in improving the market for aspirin (paying for research, marketing, etc.) when the benefit of that investment would be enjoy by countless other generic makers, with Bayer reaping hardly any of it?